|
|
|
October 25, 2010
In Today's Issue
- Weight Loss Expert Loses 70lbs of Ugly Fat...
- Does Low Dose Aspirin Cut Colorectal Cancer Risk..?
- WARNING: The truth about Moles, Warts and Skintags...
Weight Loss Expert Loses 70lbs of Ugly Fat...
Discover how this weight loss expert lost 70lbs Of Ugly Belly Fat after discovering 1 really old and kinda weird tip! And even better than that, they ate all of the foods they enjoy, and still lost all the weight they wanted to. No magic pills... no fad diets... no calorie-counting... It's the best tip for real-world weight loss and it can help you finally get that trim, toned body you've been looking for... Discover more about this amazing method here...*Disclosure: compensated affiliate*
Does Low Dose Aspirin Cut Colorectal Cancer Risk..?
Dear Reader,
Fascinating finding on colorectal cancer. New Scottish research shows that low dose aspirin (75 milligrams), taken daily, has a protective effect against the development of this type of cancer.
The numbers are sobering... an estimated 102,900 new cases of colon; another 39,670 cases of rectal cancer will be diagnosed in the United States during 2010. The good news coming out of this work is that even aspirin taken at the lowest dose helps, and the protective effect takes hold after only one year.
Earlier work had shown aspirin does protect against colorectal cancer, but no research has determined the best dose, and how long it has to be taken.
Aspirin has yet to be added to recommendations for treating colorectal cancer due to the questions on dosage, how long you need to be taking it and its effect on survival. Some studies have suggested a higher dose of aspirin might be needed, but this latest case controlled research finds that a lower dose is enough to provide protection.
The team from the University of Edinburgh examined medical records for almost 2,800 patients (ages 16 to 79 years) who had colorectal cancer; with 3,000 others matched for sex, age and where they live as controls.
The subjects had completed food frequency and lifestyle habit questionnaires to give a picture of typical diet and lifestyle choices, known to have an affect on the risk of developing colorectal cancer. The researchers then tracked the colorectal cancer survivors and those who were diagnosed with the disease over a five-year period.
The study found that taking low dose aspirin every day was tied to a 22% reduced risk of colorectal cancer. After five years, the risk dropped by 30%. What was truly intriguing about the research was that increasing the aspirin dose might not be helpful.
Continues below...
*Highly Recommended*
WARNING: The truth about Moles, Warts and Skintags...
There are so many "scare" stories that it's sometimes hard to know what to believe. Which is why this is so timely... Announcing the breakthrough solution by Chris Gibson, a respected natural health practitioner, that gets rid of moles, warts and skin tags without any expensive medical procedures or over-the-counter products. Chris has written several books on alternative health and wellness and appeared on various TV channels like Fox 26 News and CBS. Find out how you, too, can: - Have freedom from the pain and irritation of your unsightly moles, warts, or skin tags - Naturally REMOVE moles, warts, or skin tags at the root without any scarring - Enjoy having clear skin, free from unsightly and painful moles, warts or skin tags
Click through now to discover safe, painless and effective ways to permanently remove moles, warts or skin tags in three days...
*Disclosure: compensated affiliate*
Does Low Dose Aspirin Cut Colorectal Cancer Risk..? Continued...
What's more, 354 (15.5%) of those with colorectal cancer were taking low dose
aspirin, compared to 526 (18.0%) of those who were cancer free. Any nonsteroidal
anti-inflammatory drug (NSAID, for short) like aspirin, ibuprofen and naproxen
appear to provide a protective benefit. The association was seen in both men
and women, but was significant for male subjects.
Another interesting study finding? Taking NSAIDs regularly before colorectal
cancer diagnoses does not impact survival time. This effect could be due to the
sample size or a limited duration of intake in the subjects according to the
researchers. The team could not say if the subjects continued taking the aspirin
after their diagnosis.
The results of this work, while promising, need to be confirmed by future studies,
especially since some of the research in the area of aspirin and colorectal cancer
has brought mixed results. Today many Americans are taking aspirin for heart
disease, and increasing this dose is not a recommendation that will come from
your doctor anytime soon due to the risk of harmful side effects from aspirin,
compared to still uncertain benefits.
Colorectal cancer screening is an important way to protect yourself from this
dangerous disease. These tests can detect and remove colorectal polyps before
they get the chance to grow into cancer. A good rule of thumb is to follow the
American Cancer Society recommendation; men and women over 50 should be screened
each year.
To your good health,
Kirsten Whittaker
Daily Health Bulletin Editor
P.S: Nike...Ebay...Amazon and Walmart pay for your opinion
Fortune 500 companies make their money by people like you and I buying their products.
But how do they know what we want to buy? Easy they pay to find out the products we like, where we shop and what we buy.
In a nutshell big businesses need people to tell them what products to make.
People like Michelle McAllister - a 34 year old full-time mother of two. Michelle and many others help "big business" make millions, although they haven't got any marketing or sales experience.
In fact Michelle knows absolutely nothing about business, but she does know what she likes...
And that's exactly the information these companies are after and will pay you for.
Click through to discover how Michelle quickly profits by telling big companies her opinion and how you can do it too...
*Disclosure: compensated affiliate*
Sources:
http://www.webmd.com/cancer/news/20100915/low-dose-aspirin-lowers-risk-of-colorectal-cancer?src=RSS_PUBLIC
WebMD info on aspirin:
http://www.webmd.com/drugs/mono-3-ASPIRIN+-+ORAL.aspx?drugid=1082&drugname=Aspirin+Oral
American Cancer Society info on colon cancer:
http://www.cancer.org/Cancer/ColonandRectumCancer/index
Din, F. GUT, September 2010:
http://gut.bmj.com/content/early/2010/08/12/gut.2009.203000.abstract
You are receiving this email because you signed up to
. Daily Health Bulletin sends you information and research which is believed to be reliable, but its accuracy cannot be guaranteed. The content of this email bulletin is provided for information only and may not be construed as medical advice or instruction. No action or inaction should be taken based on the contents of this email bulletin alone; instead readers should consult a qualified health professional on any matter relating to their health and well-being. The information and opinions in this email bulletin are believed to be accurate and sound. Readers who fail to consult with appropriate health authorities assume the risk of any injuries. The publisher is not responsible for errors or omissions.
Want more?
Visit Daily Health Bulletin website.
To get the very latest breakthrough information and natural treatment news.
Query?
All correspondence should be sent to support@reallyworks.org
I really appreciate all the emails readers send in and I do my best to answer them all whenever possible. However, due to the high number of emails I receive I can't guarantee an individual reply. So, for this reason I try to answer your queries and health concerns through this bulletin so everyone can benefit.
Do you know someone who'd love to receive the Daily Health Bulletin?
Email address change?
Change your details here
To end your subscription
Click on the link to unsubscribe from the Daily Health Bulletin
Daily Health Bulletin | Archives | How To White list
Copyright 2008-10. All Rights Reserved. The content of this Bulletin and website
may not be redistributed in any way without written consent of Daily Health Bulletin.
| |
